Orphan designation: acalabrutinib Treatment of mantle cell lymphoma, 21/03/2016 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 10:35

Orphan designation: acalabrutinib Treatment of mantle cell lymphoma, 21/03/2016 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-16-1625

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters